Rajat Thawani

Saitama Medical University

H指数:21

被引数:2,462

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International Consensus on Severe Lung Cancer-The Second Edition

国际重症肺癌共识（第二版）

Translational Lung Cancer Research

IF3.5

2026-04-300

PRE

Lin, Xinqing; Chu, Qian; Dong, Yuchao; Li, Min; Lv, Tangfeng; Lin, Gen; Sang, Ling; Tian, Panwen; Xia, Yang; Xie, Zhanhong; Chen, Haiming; Hong, Cheng; Jiang, Juan; Jin, Haoru; Kuai, Zhongkai; Liu, Ming; Luo, Weizhan; Luo, Yongbei; Miao, Qian; Mo, Wei; Pu, Dan; Qiu, Yuan; Qian, Zhe; Sun, Jiancong; Shi, Hui; Sun, Qinying; Sun, Yutao; Yu, Zihui; Xie, Xiaohong; Xu, Wanting; Yi, Minxiao; Yuan, Dongmei; Zhang, Longfeng; Zhao, Fei; Zhong, Changhao; Zhan, Ping; Zheng, Xiaobin; Bai, Cunxue; Chen, Enguo; Chen, Rui; Chen, Xin; Cheng, Yuan; Chen, Quanfang; Cai, Linbo; Cai, Xiuyu; Chen, Liangan; Chen, Yan; Dong, Wen; Deng, Haiyi; Fang, Wenfeng; Gan, Xin; Hao, Yue; Hu, Weidong; He, Yong; Hu, Yi; Hu, Jie; Han, Baohui; Hu, Chengping; Hu, Minjuan; Jiang, Yongliang; Jin, Yang; Liu, Dan; Liu, Weiting; Li, Wen; Li, Jing; Liu, Laiyu; Liu, Jun; Li, Weifeng; Liang, Wenhua; Lin, Jie; Liu, Hongbing; Li, Ziming; Li, Weimin; Lu, NiHong; Lu, Shun; Mu, Chuanyong; Ma, Hongxia; Miao, Liyun; Mu, Xinlin; Pu, Xingxiang; Peng, Jing; Peng, Hongbing; Qin, Jianwen; Qin, Yinyin; Ren, Shengxiang; Sun, Longhua; Su, Chunxia; Song, Yong; Tan, Xiaowu; Tang, Kejing; Tang, Xiaomei; Tong, Jianlin; Wang, Wenxian; Wu, Di; Wu, Lin; Wang, Mengzhao; Wang, Huijuan; Wang, Yuehong; Wang, Hongmei; Wang, Qi; Wang, Zhijie; Wang, Jie; Wang, Kai; Wang, Fei; Xu, Chunwei; Xie, Min; Xu, Aiguo; Xiao, Kui; Xu, Xin; Xu, Fei; Ye, Xianwei; Yang, Meng; Yang, Boyan; Ye, Xiaoqun; Ye, Feng; Yu, Zongyang; Yue, Dongsheng; Zhang, Qichuan; Zou, Juntao; Zhang, Jian; Zhuang, Li; Zhou, Jianying; Zhou, Jianya; Zhang, Bicheng; Zhang, Jian; Zhang, Jianqing; Zhang, Xiaoju; Zhao, Wei; Zhu, Bo; Zhu, Zhengfei; Zhong, Wenzhao; Zhou, Caicun; Zhou, Yanbin; He, Jianxing; Zhong, Nanshan; Saito, Yuichi; Watanabe, Satoshi; Petrella, Francesco; Nakada, Takeo; Goto, Taichiro; Fiorelli, Alfonso; Solli, Piergiorgio; Berardi, Rossana; Ichiki, Yoshinobu; Braun, Marcin; Nagasaka, Misako; Chouaid, Christos; Thawani, Rajat; Santa-Catalina, Pedro Gonzalez; Styrvoky, Kim; Abbar, Baptiste; Provencio, Mariano; Li, Shiyue; Chen, Rongchang; Zhou, Chengzhi

Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC)

EGFR突变非小细胞肺癌（NSCLC）的管理进展

Current Oncology Reports

IF5

2026-04-110

OAAI

Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies

评估组织非特异性批准在胸部及头颈部恶性肿瘤中的应用

Cancers

IF4.4

2026-03-060

OAAI

Time toxicity in previously untreated metastatic or unresectable epidermal growth factor receptor-mutant non-small cell lung cancer: a clinical practice review

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2025-10-310

PRE

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较（FRONT-BRAF）：一项多中心、回顾性队列研究

The Lancet Oncology

IF0

2025-09-290

PRE

Alessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti

Clinically Explainable Prediction of Immunotherapy Response Integrating Radiomics and Clinico-Pathological Information in Non-Small Cell Lung Cancer

临床可解释的免疫治疗反应预测：整合放射组学和临床病理信息在非小细胞肺癌中的应用

Cancers 2025, Vol. 17, Page 2679

IF4.4

2025-08-200

PRE

SUPE_R Surveillance? PET/CT in Post-Treatment NSCLC and the Imperative of Proof Before Practice

超分期监测？治疗后NSCLC的PET/CT及实践前的必要性证明

Journal of Thoracic Oncology

IF20.8

2025-08-040

PRE